Back to Interventions

Substance / Medication

Flumetasone

SNOMED 116598007 UMLS C0016294

Overview

Active Ingredient

flumethasone

RxNorm CUI

4458

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Atopic dermatitis

Contact dermatitis

Skin and subcutaneous tissue disease

Atopic neurodermatitis

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

LOINC 711-2

secondary

LOINC 19113-0

secondary

Clinical Trials

162 trials linked to this intervention

162

Total Trials

28

Recruiting

66

With Results

Recent Trials

A Study to Evaluate Raptiva in Combination With Topical Psoriasis Therapies

NCT00096980Phase 4Completed300 enrolled

Utilization of Narrow Band Ultraviolet B (UVB) Light Therapy and Etanercept for the Treatment of Psoriasis

NCT00110981Phase 4Completed86 enrolled

Enbrel® in Psoriatic Arthritis

NCT00111124Phase 4Completed

Study Evaluating Etanercept and Methotrexate in Plaque Psoriasis

NCT00161655Phase 4Completed60 enrolled

Study Evaluating Etanercept in the Treatment of Subjects With Psoriasis

NCT00195507Phase 4Completed720 enrolled

View all 162 trials on ClinicalTrials.gov

Research Evidence

Published studies and systematic reviews

Sort:

Disposable nappies for preventing napkin dermatitis in infants.

Baer E L, Davies M W, Easterbrook K J · Cochrane Database Syst Rev · 2006

PMID: 16856040Meta-AnalysisFull text (PMC)

Topical vitamin A, or its derivatives, for treating and preventing napkin dermatitis in infants.

Davies M W, Dore A J, Perissinotto K L · Cochrane Database Syst Rev · 2005

PMID: 16235358Meta-AnalysisFull text (PMC)

Efficacy and safety of terbinafine hydrochloride spray and 3% boric acid alcohol ear drops in otomycosis.

Xu Shuai, Li Jianfeng, Ding Ling et al. · Acta Otolaryngol · 2020

PMID: 32022618RCT

Use of an emollient-containing diaper and pH-buffered wipe regimen restores skin pH and reduces residual enzymatic activity.

Gustin Jennifer, Bohman Lisa, Ogle Julie et al. · Pediatr Dermatol · 2020

PMID: 32314466RCTFull text (PMC)

Shifts in the skin microbiome associated with diaper dermatitis and emollient treatment amongst infants and toddlers in China.

Zheng Yumei, Wang Qian, Ma Laiji et al. · Exp Dermatol · 2019

PMID: 31472099RCT

A Natural Cream-to-Powder Formulation Developed for the Prevention of Diaper Dermatitis in Diaper-Wearing Infants and Children: Barrier Property and In-Use Tolerance Studies.

Gunt Hemali B, Levy Stanley B, Lutrario Celeste A · J Drugs Dermatol · 2018

PMID: 29742190RCT

Comparison of the Effectiveness of New Material Diapers versus Standard Diapers for the Prevention of Diaper Rash in Chinese Babies: A Double-Blinded, Randomized, Controlled, Cross-Over Study.

Yuan Chao, Takagi Rinko, Yao Xue-Qiu et al. · Biomed Res Int · 2018

PMID: 30035123RCTFull text (PMC)

Preventive effects of topical washing with miconazole nitrate-containing soap to diaper candidiasis in hospitalized elderly patients: A prospective, double-blind, placebo-controlled study.

Takahashi Hidenori, Oyama Noritaka, Tanaka Izumi et al. · J Dermatol · 2017

PMID: 28225185RCT

Clinical efficacy of flumetasone/salicylic acid ointment combined with 308-nm excimer laser for treatment of psoriasis vulgaris.

Dong Jie, He Yanling, Zhang Xiuying et al. · Photodermatol Photoimmunol Photomed · 2012

PMID: 22548394Observational

Pharmacokinetics of intravenous flumetasone and effects on plasma hydrocortisone concentrations and inflammatory mediators in the horse.

Knych H K, Arthur R M, McKemie D S et al. · Equine Vet J · 2019

PMID: 30080272Preclinical

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Specialists

Providers who commonly manage this intervention

Dermatology Physician

Dermatology

NUCC 207N00000X

Allergy & Immunology (Internal Medicine) Physician

Internal Medicine — Allergy & Immunology

NUCC 207RA0201X

Find a Provider

Health Goals

Goals connected through associated conditions

Promote Skin Health

Quick Facts

Type: Substance / Medication
Fully Specified Name: Flumetasone (substance)
SNOMED CT: 116598007
UMLS CUI: C0016294
RxNorm CUI: 4458

Clinical Data

This intervention maps to 14 entities in the Healos knowledge graph.

9

Conditions

2

Biomarkers

2

Specialists

0

Symptoms

162

Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.